Search for: "Apotex" Results 301 - 320 of 1,051
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2010, 9:55 pm by Patent Docs
By James DeGiulio -- Lilly's Patent for Strattera Found Invalid, Lilly Appeals to Federal Circuit Teva Pharmaceuticals USA, Mylan Pharmaceuticals, and Apotex successfully argued that Eli Lilly's patent for the ADHD drug Strattera (U.S. [read post]
21 Apr 2009, 8:20 pm
District Court for the District of New Jersey barred Apotex from launching a generic version of PULMICORT ® by granting AstraZeneca's requested temporary restraining order (see "Biotech/Pharma Docket," April 15, 2009). [read post]
9 Oct 2008, 4:01 pm
High Court (Chancery Division) Les Laboratoires Servier & Anor v Apotex Inc & Ors [2008] EWHC 2347 (Ch) (9 October 2008) Courts Plc (In Liquidation) [2008] EWHC 2339 (Ch) (09 October 2008) High Court (Queen’s Bench Division) Williams v Jervis (Lex Komatsu) [2008] EWHC 2346 (QB) (08 October 2008) Source: www.bailii.org        [read post]
23 Dec 2010, 9:39 pm by Patent Docs
After Apotex and Cobalt filed Abbreviated New Drug Applications (ANDAs) for generic ibandronate, the active ingredient in Boniva, Roche filed suit against the generic drug manufacturers in September of 2007 for infringement of U.S. [read post]
18 Sep 2009, 7:40 am
  Apotex Pty Ltd v Les Laboratoires Servier (No 2) [2009] FCA 1019. [read post]
11 Dec 2007, 8:35 pm
By Donald Zuhn -- Last month, the Federal Circuit affirmed a District Court's finding on summary judgment that Merck & Co., Inc. had not obtained favorable rulings in two prior proceedings by fraud. [read post]
31 May 2007, 4:13 pm
Apotex, 06A1131) contends that the Circuit Court failed to apply the Justices' unanimous April 30 ruling overturning the appeals court's method of judging patentability. [read post]
27 Aug 2008, 10:28 pm
In a recent decision, the Federal Circuit affirmed a district court's ruling in favor of AstraZeneca, holding that the generic drug manufacturers Apotex and Impax Laboratories infringed patents for the popular heartburn medication Prilosec® (generic form omeprazole) in filing abbreviated new drug applications (ANDAs). [read post]
20 Aug 2014, 11:09 pm by Lawrence B. Ebert
PatentDocs, in discussing the recent Apotex case on inequitable conduct, wroteThe opinion did draw an important distinction:To be clear, we agree with Apotex that Dr. [read post]
8 Nov 2016, 8:23 pm by Kate Howard
The petition of the day is: Apotex Inc. v. [read post]
21 Sep 2007, 8:19 pm
FDA Law Blog has a great post about a very interesting district court decision concerning Apotex's attempt to market generic Prilosec before AstraZeneca's pediatric exclusivity expires. [read post]
7 Apr 2009, 4:08 am
Federal Trade Commission about his dealings in 2006 with Canadian generic drugmaker Apotex Inc.Story in NY Times.Wonder when the New York Times will write about the criminal indictments against Pfizer execs and their Bextra related off-label crimes? [read post]
13 Jan 2014, 9:59 pm by Patent Docs
By Gary Cox, Craig Humphris and Donna Meredith -- In the decision of Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (order), the High Court of Australia, Australia's supreme court, confirmed that methods of medical treatment are a "manner of manufacture" and therefore represent a patentable invention in Australia. [read post]